Latest news with #LillyEndowment
Bloomberg
16-05-2025
- Business
- Bloomberg
Weight-Loss Drug Craze Boosts $80 Billion Lilly Endowment to Largest in US
By , Biz Carson, and Madison Muller Save The success of Eli Lilly & Co.'s weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the founding family's endowment become the largest private foundation in the US. At the end of 2024, the Lilly Endowment had $79.9 billion in assets, according to filings released Friday. That's about a 29% jump from a year earlier, topping the $77.2 billion of the Gates Foundation, which had held the top spot for several years. The growth in assets means the endowment will have to give away nearly $3.6 billion in 2025, up from $2.3 billion in actual charitable disbursements last year, according to the filing.
Yahoo
10-04-2025
- General
- Yahoo
Nine local non-profits receive over $134,000 in grants
TERRE HAUTE, Ind. (WTWO/WAWV) – Nine local non-profits received a financial boost on Wednesday. The Wabash Valley Community Foundation awarded over $134,000 in grants to the organizations. The funding will help non-profits accomplish things like buying new equipment and supplies and creating new programs. For the United Way of the Wabash Valley, the funding will support the Home Down Payment Assistance Program. It's a program that helps offset down payment and closing costs that might otherwise prohibit families from owning a home. 'If a family can own a home, we know that through many studies and experiences, that they will experience better health both mentally and physically. Their children will do better in school. Families will be able to put money into savings,' said Dorothy Chambers, Interim Executive Director of the United Way of the Wabash Valley. The grants are made possible by numerous endowment funds created by individuals, families, and organizations. Wabash Valley Community Foundation President and CEO Beth Tevlin said Lilly Endowment is doubling the donations they receive. She said that in Vigo County, the organization only has about $350,000 left to raise to reach just over $1 million. If the organization does that, it will receive $2 million from Lilly Endowment. A full list of Wednesday's grant recipients is below: American Red Cross – $2,500 in support of marketing costs to raise awareness of blood drives within Vigo County. City of Terre Haute – $10,000 for the purchase and installation of two water fountains in Terre Haute that are located near heavily populated walking trails. Crossroads of America Council – Boy Scouts – $10,000 to assist with membership costs and associated fees for Vigo County families. Indiana American Academy of Pediatrics – $15,000 in support of the 'Reach Out and Read' program which provides new books to children at well-child visits for the purpose of promoting early literacy and school readiness. Program is delivered and followed up by trained pediatricians. SHINE Foster Family Resources – $4,900 for the purchase of essential teen clothing and clothing racks. Terre Haute Children's Museum – $25,000 in support of making 'Toddler Tuesdays' which provides activities for children ages three months to five years old, more accessible. Terre Haute Symphony Association – $5,000 in support of afterschool and summer programming in collaboration with the YMCA and Camp Navigate. United Way of the Wabash Valley – $24,000 in support of the Home Down Payment Assistance Program. Wabash Valley Master Gardeners – $17,640 for the purchase of a tractor and additional gardening equipment. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
25-02-2025
- Sport
- Yahoo
Indy's $3M Tarkington Park upgrade includes field honoring late 'Coach Nell'
Indianapolis Mayor Joe Hogsett, alongside Indy Parks leaders, broke ground Monday on a $3 million project to add amenities including a multiuse athletic field and pickleball and tennis courts to Tarkington Park. The upgrades at the park, which the Indy Steelers youth football team calls home, are funded by a $80 million Lilly Endowment grant to Indy Parks. Allison Luthe, executive director of MLK Center Indy, who in March 2023 gave public comment in front of the Indy Parks board in favor of renaming the park's athletic field after the late Richard Donnell 'Coach Nell' Hamilton, shared what the field means for the neighborhood. 'I'm happy that it's named in his honor,' Luthe said, 'but I'm really happy for the players and the hundreds of young people that have played for him.' Prior to his death, Hamilton praised the community's effort to secure a $3 million Lilly Endowment, which will add circular walkways, additional shelters, a farmers market pavilion, and field improvements to better serve youth football leagues. "We've worked so hard for this," he wrote in his final Facebook post. Hamilton was fatally shot and killed Jan. 11, 2023, a day after that post, during an apparent road rage incident on Interstate 65 in Greenwood. His death remains unsolved. Contact IndyStar photojournalist Mykal McEldowney at 317-790-6991 or Follow him on Instagram or Twitter/X. This article originally appeared on Indianapolis Star: Indianapolis Tarkington Park upgrade adds field, pickleball, pavilion
Yahoo
12-02-2025
- Business
- Yahoo
Eli Lilly and Company's (NYSE:LLY) large institutional owners must be happy as stock continues to impress, up 4.7% over the past week
Significantly high institutional ownership implies Eli Lilly's stock price is sensitive to their trading actions 51% of the business is held by the top 11 shareholders Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business If you want to know who really controls Eli Lilly and Company (NYSE:LLY), then you'll have to look at the makeup of its share registry. With 87% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company. And things are looking up for institutional investors after the company gained US$35b in market cap last week. The one-year return on investment is currently 17% and last week's gain would have been more than welcomed. Let's take a closer look to see what the different types of shareholders can tell us about Eli Lilly. See our latest analysis for Eli Lilly Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. As you can see, institutional investors have a fair amount of stake in Eli Lilly. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Eli Lilly, (below). Of course, keep in mind that there are other factors to consider, too. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. We note that hedge funds don't have a meaningful investment in Eli Lilly. Lilly Endowment, Inc, Endowment Arm is currently the largest shareholder, with 11% of shares outstanding. For context, the second largest shareholder holds about 8.2% of the shares outstanding, followed by an ownership of 7.2% by the third-largest shareholder. Looking at the shareholder registry, we can see that 51% of the ownership is controlled by the top 11 shareholders, meaning that no single shareholder has a majority interest in the ownership. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our information suggests that Eli Lilly and Company insiders own under 1% of the company. Being so large, we would not expect insiders to own a large proportion of the stock. Collectively, they own US$1.0b of stock. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying. The general public-- including retail investors -- own 12% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders. While it is well worth considering the different groups that own a company, there are other factors that are even more important. Case in point: We've spotted 2 warning signs for Eli Lilly you should be aware of, and 1 of them doesn't sit too well with us. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
